Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Remus Pharmaceuticals's dividends per share for the
six
months ended in Mar. 2026 was ₹0.50. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.00. Its Dividend Payout Ratio for the
six
months ended in Mar. 2026 was 0.02. As of today, Remus Pharmaceuticals's Dividend Yield % is 0.14%.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Remus Pharmaceuticals (NSE:REMUS) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Remus Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 7 years, the highest Dividend Payout Ratio of Remus Pharmaceuticals was 0.03. The lowest was 0.02. And the median was 0.03.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Remus Pharmaceuticals Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 0.500000
2025-11-14
2025-11-14
0000-00-00
Cash Dividend
semi-annually
INR:INR 1.000000
INR 0.500000
2025-09-18
2025-09-18
0000-00-00
Cash Dividend
semi-annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Remus Pharmaceuticals's Dividend Yield (%) for Today is calculated as
Current Share Price is ₹734.10.
Remus Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹1.
During the past 7 years, the highest Dividend Yield of Remus Pharmaceuticals was 0.16%. The lowest was 0.04%. And the median was 0.10%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Remus Pharmaceuticals Dividends per Share Related Terms
Remus Pharmaceuticals Dividends per Share Historical Data
* Premium members only.
The historical data trend for Remus Pharmaceuticals's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:REMUS vs MCK, CAH, COR: Dividends per Share Comparison
For the Medical Distribution subindustry, Remus Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Remus Pharmaceuticals Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Remus Pharmaceuticals's Dividend Yield % falls into.
Remus Pharmaceuticals (NSE:REMUS) has a Dividends per Share of ₹1.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Remus Pharmaceuticals and its competitors.
Is Remus Pharmaceuticals' Dividends per Share too high?
Remus Pharmaceuticals' current Dividends per Share is ₹1.00. Overall, Remus Pharmaceuticals has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Remus Pharmaceuticals' Dividends per Share compare to MCK and CAH?
Remus Pharmaceuticals' Dividends per Share of ₹1.00 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Distribution company?
A good Dividends per Share depends on the Medical Distribution industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Remus Pharmaceuticals and its competitors. Remus Pharmaceuticals's current Dividends per Share is ₹1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Remus Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Remus Pharmaceuticals (NSE:REMUS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹2,071.36, compared to a current price of ₹734.10 — trading 64.6% below its estimated fair value. The current Dividends per Share is ₹1.00. Remus Pharmaceuticals' overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Remus Pharmaceuticals (NSE:REMUS), the current Dividends per Share is ₹1.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Remus Pharmaceuticals (NSE:REMUS) Overvalued in 2026?
Based on GuruFocus' analysis, Remus Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹734.10 is trading 64.6% below its estimated GF Value™ of ₹2,071.36.
GuruFocus considers Remus Pharmaceuticals to be Significantly Undervalued.
Key valuation signals for NSE:REMUS:
Dividends per Share: ₹1.00
GF Value™: ₹2,071.36 vs. price of ₹734.10 (64.6% below fair value)
No single metric tells the full story. See the NSE:REMUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.
55GF Score
Get the complete analysis for NSE:REMUS
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:REMUS has been successfully added to your 
